查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1776815

临床前影像市场：全球产业分析、市场规模、份额、成长、趋势与未来预测（2025-2032）

Preclinical Imaging Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 198 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球临床前影像市场的全面分析报告。该报告对关键市场动态进行了全面评估，包括市场驱动因素、趋势、机会和挑战，并提供了有关市场结构的详细见解。报告包含独家数据和统计数据，概述了全球临床前影像市场的预测成长轨迹（2025-2032 年）。

关键见解

  • 临床前影像市场规模（2025年）：45亿美元
  • 市场规模预测（以金额为准，2032 年）：62 亿美元
  • 全球市场成长率（2025-2032年复合年增长率）：4.6%

临床前影像市场—分析范围

临床前影像技术在药物研发和生物医学研究中发挥着至关重要的作用，它能够以非侵入性的方式可视化小动物模型中的生物过程。这些先进的影像技术能够深入了解疾病机制、药物动力学和疗效，进而加速新型治疗方法的开发。临床前影像市场提供各种影像系统，包括PET、SPECT、MRI、CT、光学影像和超音波技术，以满足製药和生物技术公司、研究机构和学术中心的需求。市场发展的驱动力包括：药物研发投入的增加、对个人化医疗的日益重视，以及提升影像解析度、敏感度和多重模式能力的技术进步。

市场成长动力：

全球临床前成像市场受多种关键因素驱动，包括製药和生物技术领域研发支出的不断增长，这推动了对用于评估候选药物的高精度、高通量成像解决方案的需求。肿瘤学和神经病学研究的日益关注，极大地促进了先进成像系统在早期疾病检测和治疗监测中的应用。 PET/MRI 和 PET/CT 结合的混合成像系统等技术创新，提供了更深入的解剖和功能洞察，推动了市场扩张。此外，政府支持临床前研究和产学合作的措施也增强了市场成长前景。

市场限制：

儘管成长前景光明，但临床前影像市场仍面临与先进影像设备和维护高成本相关的挑战，这可能会限制其在小型研究机构和学术机构中的应用。严格的监管准则和围绕动物试验的伦理考虑给市场参与者带来了额外的操作复杂性和合规负担。此外，替代性体外测试方法和竞争性药物筛检模型的出现可能会与传统的临床前影像测试形成竞争，尤其是在某些应用领域。解决成本和伦理障碍需要创新的经营模式、降低系统成本的技术进步，以及持续倡导体内成像在转化研究中的价值。

市场机会：

临床前影像市场在免疫肿瘤学、再生医学和分子影像研究领域的新兴应用推动下，提供了巨大的成长机会。影像探针和显影剂的进步使得特定分子路径的精准定位和视觉化成为可能，从而拓展了临床前影像在药物研发和生物标记检验中的效用。此外，将人工智慧和机器学习融入影像分析可以增强资料解读能力，提高工作流程效率，并缩短研究週期。战略联盟、对混合成像模式的投资以及开发经济高效、易于使用的成像系统，对于抓住这些机会并在不断发展的临床前研究领域中保持市场领先地位至关重要。

本报告回答的关键问题

  • 推动全球临床前影像市场成长的关键因素有哪些？
  • 哪些显像模式和应用推动了临床前影像的应用？
  • 技术进步如何改变临床前影像市场的竞争格局？
  • 谁是临床前影像市场的主要企业，他们采取什么策略来维持市场相关性？
  • 全球临床前影像市场的新兴趋势和未来前景是什么？

目录

第一章执行摘要

第二章 市场概述

  • 市场范围和定义
  • 市场动态
    • 驱动程式
    • 抑制因素
    • 机会
    • 主要趋势
  • 宏观经济因素
    • 全球产业展望
    • 全球GDP成长预测
  • COVID-19影响分析
  • 预测因子：相关性和影响力

第三章 加值分析

  • 产品采用分析
  • 监管状况
  • 价值链分析
  • 重大交易及合併
  • PESTLE分析
  • 波特五力分析

第四章 价格分析（2024年）

  • 主要亮点
  • 影响产品价格的关键因素
  • 按产品进行价格分析
  • 区域价格和产品偏好

第五章：全球临床前影像市场展望

  • 主要亮点
    • 市场规模预测（以数量为基础）
    • 市场规模及年成长率（以金额为准）
    • 绝对的商机
  • 市场规模分析与预测（以金额为准）
    • 历史市场规模分析（以金额为准，2019-2024）
    • 市场规模分析与预测（以金额为准，2025-2032）
  • 全球临床前影像市场（按产品）展望
    • 引言/主要发现
    • 历史市场规模分析：按产品（价值和数量，2019-2024）
    • 按产品分類的市场规模分析和预测（价值和数量基础，2025-2032 年）
      • 影像系统
      • 试剂
      • 软体与服务
    • 市场吸引力分析：按产品
  • 全球临床前影像市场展望（按模式）
    • 引言/主要发现
    • 按模式分類的历史市场规模分析（以金额为准，2019-2024 年）
    • 按模式分類的市场规模分析与预测（以金额为准，2025-2032）
      • 光学成像
      • 核分子影像
      • 微型磁振造影
      • 微超音波
      • 微型CT
      • 光声成像（PAT）
      • 磁粒子成像
      • 其他的
    • 按模式进行市场吸引力分析
  • 全球临床前成像市场应用展望
    • 引言/主要发现
    • 按应用分類的历史市场规模分析（以金额为准，2019-2024）
    • 按应用分類的市场规模分析和预测（以金额为准，2025-2032）
      • 研究与开发
      • 药物研发
    • 市场吸引力分析：按应用
  • 全球临床前影像市场（按最终用户）展望
    • 引言/主要发现
    • 按最终用户分類的历史市场规模分析（以金额为准，2019-2024 年）
    • 最终用户的市场规模分析与预测（以金额为准，2025-2032）
      • 製药和生物技术公司
      • 学术研究机构
      • 诊断影像中心
      • 其他的
    • 最终用户的市场吸引力分析

6. 全球临床前影像市场（按地区）展望

  • 主要亮点
  • 按地区分類的历史市场规模分析（以金额为准，2019-2024 年）
  • 各地区市场规模分析及预测（以金额为准，2025-2032）
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

7. 北美临床前影像市场展望

8. 欧洲临床前影像市场展望

9. 东亚临床前影像市场展望

10. 南亚和大洋洲临床前影像市场展望

11. 拉丁美洲临床前影像市场展望

12. 中东和非洲临床前影像市场展望

第十三章竞争格局

  • 市场占有率分析（2024年）
  • 市场结构
    • 竞争强度图：按市场
    • 竞争对手仪表板
  • 公司简介（详情：概述、财务状况、策略、最新发展）
    • Bruker
    • Siemens Healthcare Private Limited
    • Revvity
    • FUJIFILM VisualSonics, Inc.
    • Scintica
    • MILabs BV
    • United Imaging Healthcare Co., Ltd.
    • Mediso Ltd.
    • Aspect Imaging Ltd.
    • Inviscan Imaging Systems
    • TriFoil Imaging
    • Southern Scientific Ltd.
    • Iconeus
    • MR Solutions
    • BioPAL, Inc.
    • Viscover

第十四章 附录

  • 分析方法
  • 分析假设
  • 首字母缩写和简称
简介目录
Product Code: PMRREP34717

Persistence Market Research has recently released a comprehensive report on the worldwide market for preclinical imaging. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global preclinical imaging market from 2025 to 2032.

Key Insights:

  • Preclinical Imaging Market Size (2025E): USD 4.5 Billion
  • Projected Market Value (2032F): USD 6.2 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 4.6%

Preclinical Imaging Market - Report Scope:

Preclinical imaging plays a crucial role in drug discovery and biomedical research by enabling non-invasive visualization of biological processes in small animal models. These advanced imaging modalities provide critical insights into disease mechanisms, pharmacokinetics, and treatment efficacy, accelerating the development of new therapies. The preclinical imaging market caters to pharmaceutical and biotechnology companies, research institutes, and academic centers, offering a diverse range of imaging systems, including PET, SPECT, MRI, CT, optical imaging, and ultrasound technologies. Market growth is driven by rising investment in drug development, growing emphasis on personalized medicine, and technological advancements enhancing imaging resolution, sensitivity, and multi-modality capabilities.

Market Growth Drivers:

The global preclinical imaging market is propelled by several key factors, including increasing R&D expenditure in pharmaceutical and biotechnology sectors, fueling demand for precise and high-throughput imaging solutions to evaluate new drug candidates. The growing focus on oncology and neurological research significantly contributes to the adoption of advanced imaging systems for early disease detection and treatment monitoring. Technological innovations, such as hybrid imaging systems combining PET/MRI or PET/CT, offer improved anatomical and functional insights, fostering market expansion. Furthermore, government initiatives supporting preclinical research and collaborations between industry and academia strengthen market growth prospects.

Market Restraints:

Despite promising growth prospects, the preclinical imaging market faces challenges related to high costs associated with sophisticated imaging equipment and maintenance, which can limit adoption among smaller research facilities and academic institutions. Stringent regulatory guidelines and ethical considerations surrounding animal research impose additional operational complexities and compliance burdens on market players. Moreover, the availability of alternative in-vitro testing methods and computational models for drug screening may pose competition to traditional preclinical imaging studies, particularly for certain applications. Addressing cost and ethical barriers requires innovative business models, technological advancements to reduce system costs, and continued advocacy for the value of in-vivo imaging in translational research.

Market Opportunities:

The preclinical imaging market presents significant growth opportunities driven by emerging applications in immuno-oncology, regenerative medicine, and molecular imaging research. Advances in imaging probes and contrast agents enable precise targeting and visualization of specific molecular pathways, expanding the utility of preclinical imaging in drug discovery and biomarker validation. Additionally, the integration of artificial intelligence and machine learning into image analysis enhances data interpretation, improves workflow efficiency, and accelerates research timelines. Strategic collaborations, investments in hybrid imaging modalities, and development of cost-effective and user-friendly imaging systems are crucial to capitalizing on these opportunities and maintaining market leadership in the evolving preclinical research landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the preclinical imaging market globally?
  • Which imaging modalities and applications are driving preclinical imaging adoption across research settings?
  • How are technological advancements reshaping the competitive landscape of the preclinical imaging market?
  • Who are the key players contributing to the preclinical imaging market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global preclinical imaging market?

Competitive Intelligence and Business Strategy:

These companies invest heavily in R&D to develop advanced imaging platforms, including hybrid systems and high-resolution imaging technologies, addressing diverse research requirements in oncology, cardiology, and neurology. Collaborations with academic institutions, pharmaceutical companies, and government research agencies facilitate technology adoption and market expansion. Moreover, emphasis on user-friendly software solutions, enhanced imaging probes, and comprehensive customer support services fosters market growth and strengthens competitive positioning in the rapidly advancing preclinical imaging sector.

Key Companies Profiled:

  • Bruker
  • Siemens Healthcare Private Limited
  • Revvity
  • FUJIFILM VisualSonics, Inc.
  • Scintica
  • MILabs B.V.
  • United Imaging Healthcare Co., Ltd.
  • Mediso Ltd.
  • Aspect Imaging Ltd.
  • Inviscan Imaging Systems
  • TriFoil Imaging
  • Southern Scientific Ltd.
  • Iconeus
  • MR Solutions
  • BioPAL, Inc.
  • Viscover

Preclinical Imaging Market Research Segmentation:

The preclinical imaging market encompasses a diverse range of technologies, applications, and end-user segments, addressing various research needs and disease models.

By Product

  • Imaging Systems
  • Reagents
  • Software and Services

By Modality

  • Optical Imaging
  • Nuclear Molecular Imaging
  • Micro MRI
  • Micro Ultrasound
  • Micro CT
  • Photoacoustic Tomography (PAT)
  • Magnetic Particle Imaging
  • Others

By Application

  • Research & Development
  • Drug Discovery & Development

By End-user

  • Pharmaceutical and Biotech Companies
  • Academic and Research Institutes
  • Imaging Centers
  • Others

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Preclinical Imaging Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Price Analysis, 2024A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product
  • 4.4. Regional Prices and Product Preferences

5. Global Preclinical Imaging Market Outlook

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 5.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 5.3. Global Preclinical Imaging Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product, 2019-2024
    • 5.3.3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
      • 5.3.3.1. Imaging Systems
      • 5.3.3.2. Reagents
      • 5.3.3.3. Software & Services
    • 5.3.4. Market Attractiveness Analysis: Product
  • 5.4. Global Preclinical Imaging Market Outlook: Modality
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Bn) Analysis, By Modality, 2019-2024
    • 5.4.3. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
      • 5.4.3.1. Optical Imaging
      • 5.4.3.2. Nuclear Molecular Imaging
      • 5.4.3.3. Micro MRI
      • 5.4.3.4. Micro Ultrasound
      • 5.4.3.5. Micro CT
      • 5.4.3.6. Photoacoustic Tomography (PAT)
      • 5.4.3.7. Magnetic Particle Imaging
      • 5.4.3.8. Others
    • 5.4.4. Market Attractiveness Analysis: Modality
  • 5.5. Global Preclinical Imaging Market Outlook: Application
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
    • 5.5.3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      • 5.5.3.1. Research & Development
      • 5.5.3.2. Drug Discovery & Development
    • 5.5.4. Market Attractiveness Analysis: Application
  • 5.6. Global Preclinical Imaging Market Outlook: End User
    • 5.6.1. Introduction / Key Findings
    • 5.6.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2024
    • 5.6.3. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
      • 5.6.3.1. Pharmaceutical and Biotech Companies
      • 5.6.3.2. Academic and Research Institutes
      • 5.6.3.3. Imaging Centers
      • 5.6.3.4. Others
    • 5.6.4. Market Attractiveness Analysis: End User

6. Global Preclinical Imaging Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
  • 6.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Preclinical Imaging Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Modality
    • 7.2.4. By Application
    • 7.2.5. By End User
  • 7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 7.4.1. Imaging Systems
    • 7.4.2. Reagents
    • 7.4.3. Software & Services
  • 7.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 7.5.1. Optical Imaging
    • 7.5.2. Nuclear Molecular Imaging
    • 7.5.3. Micro MRI
    • 7.5.4. Micro Ultrasound
    • 7.5.5. Micro CT
    • 7.5.6. Photoacoustic Tomography (PAT)
    • 7.5.7. Magnetic Particle Imaging
    • 7.5.8. Others
  • 7.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 7.6.1. Research & Development
    • 7.6.2. Drug Discovery & Development
  • 7.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 7.7.1. Pharmaceutical and Biotech Companies
    • 7.7.2. Academic and Research Institutes
    • 7.7.3. Imaging Centers
    • 7.7.4. Others
  • 7.8. Market Attractiveness Analysis

8. Europe Preclinical Imaging Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Modality
    • 8.2.4. By Application
    • 8.2.5. By End User
  • 8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 8.4.1. Imaging Systems
    • 8.4.2. Reagents
    • 8.4.3. Software & Services
  • 8.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 8.5.1. Optical Imaging
    • 8.5.2. Nuclear Molecular Imaging
    • 8.5.3. Micro MRI
    • 8.5.4. Micro Ultrasound
    • 8.5.5. Micro CT
    • 8.5.6. Photoacoustic Tomography (PAT)
    • 8.5.7. Magnetic Particle Imaging
    • 8.5.8. Others
  • 8.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 8.6.1. Research & Development
    • 8.6.2. Drug Discovery & Development
  • 8.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 8.7.1. Pharmaceutical and Biotech Companies
    • 8.7.2. Academic and Research Institutes
    • 8.7.3. Imaging Centers
    • 8.7.4. Others
  • 8.8. Market Attractiveness Analysis

9. East Asia Preclinical Imaging Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Modality
    • 9.2.4. By Application
    • 9.2.5. By End User
  • 9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 9.4.1. Imaging Systems
    • 9.4.2. Reagents
    • 9.4.3. Software & Services
  • 9.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 9.5.1. Optical Imaging
    • 9.5.2. Nuclear Molecular Imaging
    • 9.5.3. Micro MRI
    • 9.5.4. Micro Ultrasound
    • 9.5.5. Micro CT
    • 9.5.6. Photoacoustic Tomography (PAT)
    • 9.5.7. Magnetic Particle Imaging
    • 9.5.8. Others
  • 9.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 9.6.1. Research & Development
    • 9.6.2. Drug Discovery & Development
  • 9.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 9.7.1. Pharmaceutical and Biotech Companies
    • 9.7.2. Academic and Research Institutes
    • 9.7.3. Imaging Centers
    • 9.7.4. Others
  • 9.8. Market Attractiveness Analysis

10. South Asia & Oceania Preclinical Imaging Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Modality
    • 10.2.4. By Application
    • 10.2.5. By End User
  • 10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 10.4.1. Imaging Systems
    • 10.4.2. Reagents
    • 10.4.3. Software & Services
  • 10.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 10.5.1. Optical Imaging
    • 10.5.2. Nuclear Molecular Imaging
    • 10.5.3. Micro MRI
    • 10.5.4. Micro Ultrasound
    • 10.5.5. Micro CT
    • 10.5.6. Photoacoustic Tomography (PAT)
    • 10.5.7. Magnetic Particle Imaging
    • 10.5.8. Others
  • 10.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 10.6.1. Research & Development
    • 10.6.2. Drug Discovery & Development
  • 10.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 10.7.1. Pharmaceutical and Biotech Companies
    • 10.7.2. Academic and Research Institutes
    • 10.7.3. Imaging Centers
    • 10.7.4. Others
  • 10.8. Market Attractiveness Analysis

11. Latin America Preclinical Imaging Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Modality
    • 11.2.4. By Application
    • 11.2.5. By End User
  • 11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 11.4.1. Imaging Systems
    • 11.4.2. Reagents
    • 11.4.3. Software & Services
  • 11.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 11.5.1. Optical Imaging
    • 11.5.2. Nuclear Molecular Imaging
    • 11.5.3. Micro MRI
    • 11.5.4. Micro Ultrasound
    • 11.5.5. Micro CT
    • 11.5.6. Photoacoustic Tomography (PAT)
    • 11.5.7. Magnetic Particle Imaging
    • 11.5.8. Others
  • 11.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 11.6.1. Research & Development
    • 11.6.2. Drug Discovery & Development
  • 11.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 11.7.1. Pharmaceutical and Biotech Companies
    • 11.7.2. Academic and Research Institutes
    • 11.7.3. Imaging Centers
    • 11.7.4. Others
  • 11.8. Market Attractiveness Analysis

12. Middle East & Africa Preclinical Imaging Market Outlook

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 12.2.1. By Country
    • 12.2.2. By Product
    • 12.2.3. By Modality
    • 12.2.4. By Application
    • 12.2.5. By End User
  • 12.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 12.4.1. Imaging Systems
    • 12.4.2. Reagents
    • 12.4.3. Software & Services
  • 12.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 12.5.1. Optical Imaging
    • 12.5.2. Nuclear Molecular Imaging
    • 12.5.3. Micro MRI
    • 12.5.4. Micro Ultrasound
    • 12.5.5. Micro CT
    • 12.5.6. Photoacoustic Tomography (PAT)
    • 12.5.7. Magnetic Particle Imaging
    • 12.5.8. Others
  • 12.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 12.6.1. Research & Development
    • 12.6.2. Drug Discovery & Development
  • 12.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 12.7.1. Pharmaceutical and Biotech Companies
    • 12.7.2. Academic and Research Institutes
    • 12.7.3. Imaging Centers
    • 12.7.4. Others
  • 12.8. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Bruker
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Product
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Siemens Healthcare Private Limited
    • 13.3.3. Revvity
    • 13.3.4. FUJIFILM VisualSonics, Inc.
    • 13.3.5. Scintica
    • 13.3.6. MILabs B.V.
    • 13.3.7. United Imaging Healthcare Co., Ltd.
    • 13.3.8. Mediso Ltd.
    • 13.3.9. Aspect Imaging Ltd.
    • 13.3.10. Inviscan Imaging Systems
    • 13.3.11. TriFoil Imaging
    • 13.3.12. Southern Scientific Ltd.
    • 13.3.13. Iconeus
    • 13.3.14. MR Solutions
    • 13.3.15. BioPAL, Inc.
    • 13.3.16. Viscover

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations